Antibiotics
|
|
|
|
Ciprofloxacin |
0.85-2 |
Brown et al., 2006 [21] |
|
2.0-83 |
Kümmerer et al., 2001 [22] |
|
3.6-101 |
Lindberg et al., 2004 [23] |
|
Ofloxacin |
2.905 |
Chang et al., 2010 [24] |
|
6.67 |
Gros et al., 2013 [25] |
|
2.20 |
Passerat et al., 2010 [26] |
|
Nalidixic acid |
0.186 |
Lin et al., 2008 [27] |
|
|
<0.002-<0.005 |
Gros et al.,2013 [25] |
Tetracycline |
<0.015-4.178 |
Thomas et al., 2007 [28] |
|
<0.002-0.455 |
Lin & Tsai, 2009 [29] |
|
<0.007-0.033 |
Verlicchi et al., 2012a [30] |
|
Chloramphenicol |
<0.004-0.036 |
Verlicchi et al., 2012a [30] |
|
0.001 |
Lin et al., 2008 [31] |
|
<0.5 |
Ohlsen et al., 2003 [32] |
|
Hormones
|
|
|
Estrone |
0.007-0.04 |
Thomas et al., 2007 [28] |
|
<0.01 |
Lin et al., 2008 [31] |
|
0.025-0.415 |
Lin & Tsai, 2009 [29] |
|
17β-estradiol |
<0.003-0.072 |
Thomas et al.,2007 [28] |
|
<0.025-0.23 |
Thomas et al., 2007 [28] |
|
<0.01 |
Lin et al., 2008 [31] |
|
Estriol |
0.18-0.785 |
Thomas et al.,2007 [28] |
|
4.651 |
Lin et al., 2008 [31] |
|
17α-ethinylestradiol |
<0.003 |
Thomas et al., 2007 [28] |
|
<0.025-0.432 |
Lin & Tsai, 2009 [29] |
|
<0.0004 |
Perrodin et al., 2013 [33] |
|
Beta-blockers
|
|
|
Atenolol |
0.045-0.0053 |
Langford & Thomas, 2009 [34] |
|
0.1-122 |
Gómez et al., 2006 [35] |
|
2.2-6.6 |
Verlicchi et al., 2012b [36] |
|
Disinfectants
|
|
|
Triclosan |
<0.044 |
Kosma et al., 2010 [37] |
|
Lipid modifying agents
|
|
|
Bezafibrate |
<0.001-2.9 |
Verlicchi et al., 2012 [30] |
|
Analgesics
|
|
|
Diclofenac |
0.06-1.9 |
Gómez et al., 2006 [35] |
|
0.17-0.53 |
Verlicchi et al., 2012 [30] |
|
0.028-6.88 |
Sim et al., 2011 [38] |
|
Acetaminophen |
0.5-29 |
Gómez et al., 2006 [35] |
|
1.4-5.9 |
Verlicchi et al., 2012b [36] |
|
0.271-63.1 |
Sim et al., 2011 [37] |
|
Ibuprofen |
7-8.93 |
Kosma et al., 2010 [37] |
|
1.5-151 |
Gómez et al., 2006 [35] |
|
0.069-8.957 |
Thomas et al., 2007 [28] |
|
Ketoprofen |
0.2-0.35 |
Langford & Thomas, 2009 [34] |
|
1.1-9.8 |
Verlicchi et al., 2012 [30] |
|
<0.01-0.23 |
Lin & Tsai, 2009 [29] |